TransCode Therapeutics, Inc. - Common Stock (NQ:RNAZ)

1.570 +0.025 (+1.62%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TransCode Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 24, 2023

Via Benzinga

TransCode Therapeutics Announces Preliminary Clinical Results in First Patient in Phase 0 Clinical Study with Lead Therapeutic Candidate, TTX-MC138

October 24, 2023

Evidence of Drug Accumulation in Metastatic Lesions

From TransCode Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 16, 2023

Via Benzinga

TransCode Therapeutics Reports Successful Treatment of Preclinical Melanoma Tumors with its Immunotherapy Candidate, TTX-RIGA

October 16, 2023

Study showed a 70% Inhibition of Recurrent Tumor Growth

From TransCode Therapeutics, Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Monday ↗

October 02, 2023

On Monday, 369 companies set new 52-week lows.

Via Benzinga

TransCode Therapeutics Announces Closing of $8.5 Million Public Offering

September 28, 2023

From TransCode Therapeutics, Inc.

Via GlobeNewswire

Why Gritstone bio Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket ↗

September 28, 2023

Gainers Inpixon (NASDAQ: INPX) shares rose 44.6% to $0.2023 in pre-market trading after gaining around 10% on Wednesday.

Via Benzinga

Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 27, 2023

Gainers

Via Benzinga

Nasdaq Down 1.5%; Immunovant Shares Spike Higher ↗

September 26, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 400 points on Tuesday. The Dow traded down 1.19% to 33,601.60 while the NASDAQ fell 1.48% to 13,074.97. The S&P...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 26, 2023

Via Benzinga

Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 26, 2023

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi...

Via Benzinga

Crude Oil Moves Higher; Cintas Earnings Top Estimates ↗

September 26, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday. The Dow traded down 0.96% to 33,681.79 while the NASDAQ fell 1.24% to 13,106.70. The S&P 500...

Via Benzinga

Topics Stocks

Why Transcode Therapeutics (RNAZ) Stock Is Down Nearly 70% ↗

September 26, 2023

Transcode Therapeutics Inc (NASDAQ: RNAZ) shares are trading lower by 69% to $0.79 Tuesday morning after the company priced its $8 million public offering of 15.7 milli

Via Benzinga

Dow Tumbles 150 Points; US House Prices Rise in July ↗

September 26, 2023

U.S. stocks traded lower this morning, with the Dow Jones falling around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.45% to 33,852.58 while the NASDAQ fell 0.74%...

Via Benzinga

Topics Stocks

TSLA Stock Alert: What to Know as Tesla Faces EU Anti-Subsidy Probe ↗

September 26, 2023

Tesla stock is in the news as investors in TSLA react to reports the company could be subjected to an anti-subsidy probe from the EU!

Via InvestorPlace

Why Is Safe & Green (SGBX) Stock Down 6% Today? ↗

September 26, 2023

Safe & Green stock is sliding lower on Tuesday as the company prepares for the distribution of SGDVV stock tomorrow as part of a spinoff!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 26, 2023

Via Benzinga

Why Is TransCode Therapeutics (RNAZ) Stock Down 69% Today? ↗

September 26, 2023

TransCode Therapeutics stock is falling hard on Tuesday after the medical company announced a public offering for RNAZ shares.

Via InvestorPlace

Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise

September 26, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:VACC),(NASDAQ:BPTS),(NASDAQ:RNAZ),(NYSE:BMY) EQNX::TICKER_END

Via FinancialNewsMedia

Why Femasys Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket ↗

September 26, 2023

Gainers Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

September 26, 2023

Pre-market stock movers are among the biggest topics worth checking out on Tuesday and we have the latest news for investors!

Via InvestorPlace

TransCode Therapeutics Announces Pricing of $8 Million Public Offering

September 25, 2023

From TransCode Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 25, 2023

Via Benzinga

Gold Moves Lower; TransCode Therapeutics Shares Surge ↗

September 25, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday. The Dow traded down 0.07% to 33,939.93 while the NASDAQ rose 0.24% to...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 25, 2023

Via Benzinga

Why Is TransCode Therapeutics (RNAZ) Stock Up 240% Today? ↗

September 25, 2023

With TransCode Therapeutics delivering positive pre-clinical results for its brain tumor candidate, RNAZ stock soared on the implications.

Via InvestorPlace

Nasdaq Turns Higher; SCYNEXIS Shares Plunge ↗

September 25, 2023

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite trading higher on Monday. The Dow traded down 0.01% to 33,962.53 while the NASDAQ rose 0.26% to 13,246.15. The S&P 500...

Via Benzinga

Topics Stocks

Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

September 25, 2023

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.

Via Benzinga

Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories ↗

September 25, 2023

Benzinga

Via Benzinga

Why Is Brain Cancer Focused TransCode Therapeutics Stock Trading 300% Higher Today? ↗

September 25, 2023

TransCode Therapeutics Inc (NASDAQ: RNAZ) shares are trading higher after the company announced results with its lead therapeutic candidate, TTX-MC138, in murine models bearing human glioblastoma

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.